Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy

Annals of the New York Academy of Sciences

Volumn 1051, Issue , 2005, Pages 606-612

  Ruiz Irastorza, Guillermo ^a   Khamashta, Munther A ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antiphospholipid syndrome; Pregnancy; Systemic lupus erythematosus; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; CALCIUM; DALTEPARIN; DICOUMAROL DERIVATIVE; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PHOSPHOLIPID ANTIBODY; VITAMIN D;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; BLEEDING; COMPLEMENT ACTIVATION; CONFERENCE PAPER; FETUS WASTAGE; HIGH RISK POPULATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LACTATION; OSTEOPOROSIS; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PUERPERIUM; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 25444463821     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1361.105     Document Type: Conference Paper

References (34)

1. BAZAAN, M. & V. DONVITO. 2001. Low-molecular-weight heparin during pregnancy. Throm. Res. 101: V175-V186.
2. RUIZ-IRASTORZA, G., M.A. KHAMASHTA & G.R.V. HUGHES. 2002. Hughes syndrome crosses boundaries. Autoimmun. Rev. 1: 43-48.
3. GIRARDI, G., P. REDECHA & J.E. SALMON. 2004. Heparin prevents antiphospholid antibody-induced fetal loss by inhibiting complement activation. Nat. Med. 10: 1222-1226.
4. LEVINE, J.S., D.W. BRANCH & J. RAUCH. 2002. The antiphospholipid syndrome. N. Engl. J. Med. 346: 752-763.
5. KHAMASHTA, M.A., M.J. CUADRADO, F. MUJIC, et al. 1995. The management of thrombosis in the antiphospholipid-antibody syndrome. N. Engl. J. Med. 332: 993-997.
6. ROSOVE, M.H. & P.M.C. BREWER. 1992. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann. Intern. Med. 117: 303-308.
7. SCHULMAN, S., E. SVENUNGSSON, S. GRANQVIST, et al. 1998. Anticardiolipin antibodies predict early recurrence in thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am. J. Med. 104: 332-338.
8. KEARON, C., M. GENT, J. HIRSH, et al. 1999. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N. Engl. J. Med. 340: 901-907.
9. DERKSEN, R.H.W.M., M.A. KHAMASHTA & D.W. BRANCH. 2004. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum. 50: 1028-1039.
10. ERKAN, D., J.T. MERRILL, Y. YAZICI, et al. 2001. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum. 44: 1466-1467.
11. RAI, R., H. COHEN, M. DAVE L. REGAN. 1997. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br. Med. J. 314: 253-257.
12. FARQUHARSON, R.G., S. QUENBY & M. GREAVES. 2002. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet. Gynecol. 100: 408-413.
13. SILVER, R.K., S.N. MACGREGOR, J.S. SHOLL, et al. 1993. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am. J. Obstet. Gynecol. 169: 1411-1417.
14. LIMA, F., M.A. KHAMASHTA, N.M.M. BUCHANAN, et al. 1996. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin. Exp. Rheumatol. 14: 131-136.
15. GRANGER, K.A. & R.G. FARQUHARSON. 1997. Obstetric outcome in antiphospholipid syndrome. Lupus 6: 509-513.
16. PATTISON, N.S., L.W. CHAMLEY, M. BIRDSALL, et al. 2000. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am. J. Obstet. Gynecol. 183: 1008-1012.
17. HUONG, D.L.T., B. WECHSLER, O. BLETRY, et al. 2001. A study of 75 pregnancies in patients with antiphospholipid syndrome. J. Rheumatol. 28: 2025-2030.
18. MUÑOZ-RODRIGUEZ, F.J., J. FONT, R. CERVERA, et al. 1999. Clinical study of 100 patients with the antiphospholipid syndrome. Semin. Arthritis Rheum. 29: 182-190.
19. RUIZ-IRASTORZA, G., M.A. KHAMASHTA & G.R.V. HUGHES. 2002. Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun. Rev. 1: 298-304.
20. SANSON, B.J., A.W.A. LENSING, M.H. PRINS, et al. 1999. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb. Haemost. 81: 668-672.
21. BRANCH, D.W. & M.A. KHAMASHTA. 2003. Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet. Gynecol. 101: 1333-1344.
22. BATES, S., I.A. GREER, J. HIRSH & J.S. GINSBERG. 2004. Use of antithrombotic agents during pregnancy. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126: 627S-644S.
23. Wetzl, R.G. 2004. Anestesiological aspects of pregnancy in patients with rheumatic diseases. Lupus 13: 699-702.
24. PAUZNER, R., M. DULITZKI, P. LANEVITZ & M.A. KENETT. 2001. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb. Haemost. 86: 1379-1384.
25. JILMA, B., S. KAMATH & G.Y.H. LIP. 2003. Antithrombotic therapy in special circumstances. I - pregnancy and cancer. Br. Med. J. 326: 37-40.
26. NELSON-PIERCY, C., E. LETSKY & M. DE SWIET. 1997. Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am. J. Obstet. Gynecol. 176: 1062-1068.
27. HUNT, B.J., H.A. DOUGHTY, G. MAJUMDAR, et al. 1997. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb. Haemost. 77: 39-43.
28. BRITISH COMMITTEE FOR STANDARDS IN HAEMATOLOGY. 1998. Guidelines on oral anti-coagulation, 3rd ed. Br. J. Haematol. 101: 374-387.
29. RUIZ-IRASTORZA, C. NELSON-PIERCY & G.R. HUGHES. 2001. Lupus pregnancy: is heparin a risk factor for osteoporosis? Lupus 10: 597-600.
30. RUIZ-IRASTORZA, G., M.A. KHAMASHTA & G.R. HUGHES. 2002. Heparin and osteoporosis during pregnancy: 2002 update. Lupus 11: 680-682.
31. RUIZ-IRASTORZA, G., M.A. KHAMASHTA, B.J. HUNT, et al. 2002. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. Arch. Intern. Med. 162: 1164-1169.
32. CUADRADO, M.J., L.L.F. MENDONÇA, M.A. KHAMASHTA, et al. 1999. Maternal and fetal outcome in antiphospholipid syndrome pregnancies with a history of previous cerebral ischemia [Abstract]. Arthritis Rheum. 42: S265.
33. HUNT, B.J., M.A. KHAMASHTA, L. LAKASING, et al. 1998. Thromboprophylaxis in antiphospholipid syndrome pregnancies with previous cerebral arterial thrombotic events: is warfarin preferable? Thromb. Haemost. 79: 1060-1061.
34. PIERANGELI, S.S., M. VEGA-OSTERTAG, X. LIU, et al. 2004. An anti C5 monoclonal antibody reverses antiphospholipid-induced thrombosis [abstract]. Arthritis Rheum. 50: S639-S640.